4,970
Participants
Start Date
May 31, 2007
Study Completion Date
June 30, 2038
Anti TNF therapy including infliximab
Treatments will be prescribed according to investigator judgement.
No Biologics
Treatments will be prescribed according to investigator judgement.
Mobile
Phoenix
Los Angeles
Oakland
Sacramento
San Diego
San Francisco
Aurora
Hartford
New Haven
Gainesville
Miami
Orlando
Atlanta
Boise
Chicago
Lexington
New Orleans
Portland
Boston
Newton
Worcester
Detroit
Southfield
Minneapolis
Rochester
Boys Town
Las Vegas
Manchester
Mays Landing
Morristown
Brooklyn
Buffalo
Lake Success
Mineola
New York
Stony Brook
Syracuse
The Bronx
Williamsville
Chapel Hill
Durham
Oklahoma City
Danville
Philadelphia
Greenville
Knoxville
Memphis
Dallas
Fort Worth
San Antonio
Burlington
Charlottesville
Fairfax
Norfolk
Seattle
Madison
Milwaukee
Edmonton
Halifax
Burlington
Toronto
Lead Sponsor
Janssen Biotech, Inc.
INDUSTRY